1-13 of 13
primary amyloidosis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Search for AL amyloidosis risk factors using Mendelian randomization

Charlie N. Saunders, Subhayan Chattopadhyay, Stefanie Huhn, Niels Weinhold, Per Hoffmann, Markus M. Nöthen, Karl-Heinz Jöckel, Börge Schmidt, Stefano Landi, Hartmut Goldschmidt, Paolo Milani, Giampaolo Merlini, Dorota Rowcieno, Philip Hawkins, Ute Hegenbart, Giovanni Palladini, Ashutosh Wechalekar, Stefan O. Schönland, Asta Försti, Richard Houlston, Kari Hemminki
Journal: Blood Advances
Blood Adv (2021) 5 (13): 2725–2731.
https://doi.org/10.1182/bloodadvances.2021004423
Published: 2021
Includes: Supplemental data
Journal Articles

IGVL gene region usage correlates with distinct clinical presentation in IgM vs non-IgM light chain amyloidosis

Clinical Trials & Observations
Surbhi Sidana, Surendra Dasari, Taxiarchis V. Kourelis, Angela Dispenzieri, David L. Murray, Rebecca L. King, Ellen D. McPhail, Marina Ramirez-Alvarado, Shaji K. Kumar, Morie A. Gertz
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2101–2105.
https://doi.org/10.1182/bloodadvances.2020003671
Published: 2021
Includes: Supplemental data
Journal Articles

Prognostic restaging after treatment initiation in patients with AL amyloidosis

Clinical Trials & Observations
Nadine Abdallah, Angela Dispenzieri, Eli Muchtar, Francis K. Buadi, Prashant Kapoor, Martha Q. Lacy, Yi L. Hwa, Amie Fonder, Miriam A. Hobbs, Suzanne R. Hayman, Nelson Leung, David Dingli, John A. Lust, Ronald S. Go, Yi Lin, Wilson I. Gonsalves, Taxiarchis Kourelis, Rahma Warsame, Robert A. Kyle, S. Vincent Rajkumar, Morie A. Gertz, Shaji K. Kumar
Journal: Blood Advances
Blood Adv (2021) 5 (4): 1029–1036.
https://doi.org/10.1182/bloodadvances.2020003782
Published: 2021
Journal Articles

Sequential response-driven bortezomib-based therapy followed by autologous stem cell transplant in AL amyloidosis

Clinical Trials & Observations
Marco Basset, Paolo Milani, Mario Nuvolone, Francesca Benigna, Lara Rodigari, Andrea Foli, Giampaolo Merlini, Giovanni Palladini
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4175–4179.
https://doi.org/10.1182/bloodadvances.2020002219
Published: 2020
Includes: Supplemental data
Journal Articles

Assessment of minimal residual disease using multiparametric flow cytometry in patients with AL amyloidosis

Clinical Trials & Observations
Andrew Staron, Eric J. Burks, John C. Lee, Shayna Sarosiek, J. Mark Sloan, Vaishali Sanchorawala
Journal: Blood Advances
Blood Adv (2020) 4 (5): 880–884.
https://doi.org/10.1182/bloodadvances.2019001331
Published: 2020
Journal Articles

Organ responses with daratumumab therapy in previously treated AL amyloidosis

Clinical Trials & Observations
Alfred Chung, Gregory P. Kaufman, Surbhi Sidana, Erik Eckhert, Stanley L. Schrier, Richard A. Lafayette, Sally Arai, Ronald M. Witteles, Michaela Liedtke
Journal: Blood Advances
Blood Adv (2020) 4 (3): 458–466.
https://doi.org/10.1182/bloodadvances.2019000776
Published: 2020
Journal Articles

Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone

Efstathios Kastritis, Ioanna Dialoupi, Maria Gavriatopoulou, Maria Roussou, Nikolaos Kanellias, Despina Fotiou, Ioannis Ntanasis-Stathopoulos, Elektra Papadopoulou, Dimitrios C. Ziogas, Kimon Stamatelopoulos, Efstathios Manios, Argyrios Ntalianis, Evangelos Eleutherakis-Papaiakovou, Asimina Papanikolaou, Magdalini Migkou, Aristea-Maria Papanota, Harikleia Gakiopoulou, Erasmia Psimenou, Maria Irini Tselegkidi, Ourania Tsitsilonis, Ioannis Kostopoulos, Evangelos Terpos, Meletios A. Dimopoulos
Journal: Blood Advances
Blood Adv (2019) 3 (20): 3002–3009.
https://doi.org/10.1182/bloodadvances.2019000147
Published: 2019
Includes: Supplemental data
Journal Articles

Comparison of different techniques to identify cardiac involvement in immunoglobulin light chain (AL) amyloidosis

Mohammed A. Aljama, M. Hasib Sidiqi, Angela Dispenzieri, Morie A. Gertz, Martha Q. Lacy, Francis K. Buadi, David Dingli, Eli Muchtar, Amie L. Fonder, Suzanne R. Hayman, Miriam A. Hobbs, Wilson I. Gonsalves, Rahma M. Warsame, Taxiarchis Kourelis, Yi Lisa Hwa, Prashant Kapoor, Nelson Leung, Ronald S. Go, Robert A. Kyle, S. Vincent Rajkumar, Shaji K. Kumar
Journal: Blood Advances
Blood Adv (2019) 3 (8): 1226–1229.
https://doi.org/10.1182/bloodadvances.2019032458
Published: 2019
Journal Articles

Delay treatment of AL amyloidosis at relapse until symptomatic: devil is in the details

Vaishali Sanchorawala
Journal: Blood Advances
Blood Adv (2019) 3 (2): 216–218.
https://doi.org/10.1182/bloodadvances.2018021261
Published: 2019
Journal Articles

When should treatment of AL amyloidosis start at relapse? Early, to prevent organ progression

Clinical Trials & Observations
Giovanni Palladini, Giampaolo Merlini
Journal: Blood Advances
Blood Adv (2019) 3 (2): 212–215.
https://doi.org/10.1182/bloodadvances.2018021253
Published: 2019
Journal Articles

Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myeloma

Tilmann Bochtler, Maximilian Merz, Thomas Hielscher, Martin Granzow, Korbinian Hoffmann, Alwin Krämer, Marc-Steffen Raab, Jens Hillengass, Anja Seckinger, Christoph Kimmich, Tobias Dittrich, Carsten Müller-Tidow, Dirk Hose, Hartmut Goldschmidt, Ute Hegenbart, Anna Jauch, Stefan O. Schönland
Journal: Blood Advances
Blood Adv (2018) 2 (20): 2607–2618.
https://doi.org/10.1182/bloodadvances.2018023200
Published: 2018
Includes: Supplemental data
Journal Articles

Epidemiology of AL amyloidosis: a real-world study using US claims data

Tiffany P. Quock, Tingjian Yan, Eunice Chang, Spencer Guthrie, Michael S. Broder
Journal: Blood Advances
Blood Adv (2018) 2 (10): 1046–1053.
https://doi.org/10.1182/bloodadvances.2018016402
Published: 2018
Includes: Supplemental data
Journal Articles

Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation

Clinical Trials & Observations
M Hasib Sidiqi, Mohammed A. Aljama, Eli Muchtar, Francis K. Buadi, Rahma Warsame, Martha Q. Lacy, Angela Dispenzieri, David Dingli, Nelson Leung, Wilson I. Gonsalves, Shaji K. Kumar, Prashant Kapoor, Taxiarchis V. Kourelis, William J. Hogan, Morie A. Gertz
Journal: Blood Advances
Blood Adv (2018) 2 (7): 769–776.
https://doi.org/10.1182/bloodadvances.2018016782
Published: 2018
Includes: Supplemental data